Shares in local drugmaker SCI Pharmtech Inc (SCI, 旭富製藥) rose 0.5 percent to NT$60.8 yesterday, weaker than the TAIEX’s 0.85 percent increase, Taiwan Stock Exchange data showed, one day after the company trimmed its capital by NT$380,000 (US$11,988).
The Taoyuan-based company cut its capital by buying back 38,000 common shares from employees and therefore raised its net worth to NT$31.28 per share, from the previous NT$31.27, according to its stock filing.
As of yesterday, SCI shares had fallen 2.09 percent this year, more than the main bourse’s 0.6 percent retreat and the chemical sector’s 1.3 percent slide, the TAIEX said.
Still, Fubon Securities Co (富邦證券) maintained a “buy” rating for the drugmaker, as the company is set to benefit from order reallocations by some clients and its sales of primary drug pipelines remain healthy.
“We maintain our positive earnings outlook for its main drug pipelines,” Fubon research analyst Heather Chang (張雅雯) said in a report.
SCI is an affiliate of Mercuries & Associates Ltd (三商行), whose business interests include Mercuries Life Insurance Co (三商美邦人壽), Mercuries Data Systems Ltd (三商電腦), supermarket chain Simple Mart (美廉社), shoe retailer Family Shoes (鞋全家福), beef noodle chain Sanshang Chiaofu (三商巧福) and other ventures.
The drugmaker is one of the nation’s leading pharmaceutical active-ingredient providers and has expanded into diet, anti-depression and HIV/AIDS medications in recent years to diversify its revenue sources.
SCI is poised to benefit from order reallocations by certain customers, Chang said, adding that primary drug pipelines’ sales look healthy, with a still-intact growth history from gross margin expansions and long-term operations.
The active-pharmaceutical ingredients category used to make hydroxychloroquine, a medicine used to treat or prevent malaria, lupus and rheumatoid arthritis, is on course to outperform estimates, with shipments forecast to surge from 3.3 tonnes last year to 20 tonnes this year, the report said.
At the same time, SCI’s antidepressants unit has struck a new deal with an Indian pharmaceutical firm, with initial shipments to begin soon, the report said.
“We expect antidepressant sales to deliver outstanding growth from mid-year on” after SCI secured a position last year as the secondary supplier for the generic formulation of US drugmaker Eli Lilly and Co’s off-patent fluoxetine at a more competitive price.
SCI posted NT$93 million in revenue last month, down 8.86 percent from the same period last year, the stock filing showed.
As of September last year, pre-tax income totaled NT$266.88 million, or NT$3.15 earnings per share, the filing said.
Quanta Computer Inc (廣達) chairman Barry Lam (林百里) is expected to share his views about the artificial intelligence (AI) industry’s prospects during his speech at the company’s 37th anniversary ceremony, as AI servers have become a new growth engine for the equipment manufacturing service provider. Lam’s speech is much anticipated, as Quanta has risen as one of the world’s major AI server suppliers. The company reported a 30 percent year-on-year growth in consolidated revenue to NT$1.41 trillion (US$43.35 billion) last year, thanks to fast-growing demand for servers, especially those with AI capabilities. The company told investors in November last year that
Intel Corp has named Tasha Chuang (莊蓓瑜) to lead Intel Taiwan in a bid to reinforce relations between the company and its Taiwanese partners. The appointment of Chuang as general manager for Intel Taiwan takes effect on Thursday, the firm said in a statement yesterday. Chuang is to lead her team in Taiwan to pursue product development and sales growth in an effort to reinforce the company’s ties with its partners and clients, Intel said. Chuang was previously in charge of managing Intel’s ties with leading Taiwanese PC brand Asustek Computer Inc (華碩), which included helping Asustek strengthen its global businesses, the company
Taiwanese suppliers to Taiwan Semiconductor Manufacturing Co. (TSMC, 台積電) are expected to follow the contract chipmaker’s step to invest in the US, but their relocation may be seven to eight years away, Minister of Economic Affairs J.W. Kuo (郭智輝) said yesterday. When asked by opposition Chinese Nationalist Party (KMT) Legislator Niu Hsu-ting (牛煦庭) in the legislature about growing concerns that TSMC’s huge investments in the US will prompt its suppliers to follow suit, Kuo said based on the chipmaker’s current limited production volume, it is unlikely to lead its supply chain to go there for now. “Unless TSMC completes its planned six
Power supply and electronic components maker Delta Electronics Inc (台達電) yesterday said it plans to ship its new 1 megawatt charging systems for electric trucks and buses in the first half of next year at the earliest. The new charging piles, which deliver up to 1 megawatt of charging power, are designed for heavy-duty electric vehicles, and support a maximum current of 1,500 amperes and output of 1,250 volts, Delta said in a news release. “If everything goes smoothly, we could begin shipping those new charging systems as early as in the first half of next year,” a company official said. The new
RSS